![Yi Ping Rong](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 48 259 $ al 30/06/2026
Yi Ping Rong is Executive Director & Senior Vice President at Harbour BioMed (Shanghai) Co., Ltd. since 2016.
Dr. Rong is Executive Director, Chief Scientific Officer & SVP at HBM Holdings Ltd. since 2022.
Former roles include Member at The American Association of Cancer Research.
Education includes a doctorate from Case Western Reserve University conferred in 2008 and a graduate degree from East China University of Science & Technology conferred in 2002.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 05/09/2025 | 36.250 ( 0 % ) | 48 259 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| HBM HOLDINGS LIMITED | Director Técnico/Científico/I+D | 05/05/2022 |
Harbour BioMed (Shanghai) Co., Ltd.
 Harbour BioMed (Shanghai) Co., Ltd. BiotechnologyHealth Technology Engages in discovering and developing innovative therapeutics for cancer | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
The American Association of Cancer Research | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Case Western Reserve University
 Case Western Reserve University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
East China University of Science & Technology
 East China University of Science & Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harbour BioMed (Shanghai) Co., Ltd.
Harbour BioMed (Shanghai) Co., Ltd. BiotechnologyHealth Technology Engages in discovering and developing innovative therapeutics for cancer | Health Technology |
HBM Holdings Ltd.
 HBM Holdings Ltd. Pharmaceuticals: OtherHealth Technology Engages in research and development of therapeutics in the fields of immuno-oncology and immunology diseases | Health Technology |
The American Association of Cancer Research |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
